Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women (2010)

  • Authors:
  • USP affiliated authors: CARRARA, HELIO HUMBERTO ANGOTTI - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; TAKAHASHI, CATARINA SATIE - FFCLRP
  • USP Schools: FMRP; FMRP; FFCLRP
  • DOI: 10.1007/s10238-009-0079-4
  • Subjects: NEOPLASIAS MAMÁRIAS; BIOMARCADORES
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10238-009-0079-4 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Clinical and Experimental Medicine

    ISSN: 1591-8890

    Citescore - 2017: 2.19

    SJR - 2017: 0.848

    SNIP - 2017: 0.744


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP1798741-10pcd 1798741
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SANTOS, Raquel Alves dos; TEIXEIRA, Ana Claudia; MAYORANO, Mónica Beatriz; et al. Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women. Clinical and Experimental Medicine, Milano, v. 10, n. 2, p. 87-92. 2010, 2010. DOI: 10.1007/s10238-009-0079-4.
    • APA

      Santos, R. A. dos, Teixeira, A. C., Mayorano, M. B., Carrara, H. H. A., Andrade, J. M. de, & Takahashi, C. S. (2010). Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women. Clinical and Experimental Medicine, 10( 2), 87-92. 2010. doi:10.1007/s10238-009-0079-4
    • NLM

      Santos RA dos, Teixeira AC, Mayorano MB, Carrara HHA, Andrade JM de, Takahashi CS. Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women. Clinical and Experimental Medicine. 2010 ; 10( 2): 87-92. 2010.
    • Vancouver

      Santos RA dos, Teixeira AC, Mayorano MB, Carrara HHA, Andrade JM de, Takahashi CS. Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women. Clinical and Experimental Medicine. 2010 ; 10( 2): 87-92. 2010.

    Referências citadas na obra
    Hulka BS, Moorman PG (2001) Breast cancer: hormones and other risk factors. Maturitas 38:103–116
    Kristensen NS, Haraldsen EK, Anderson KB, Lonning PE, Erikstein B, Karesen R, Gabrielsen OS, Borresen-Dale AL (1999) CYP17 and breast cancer risk: the polymorphism in the 5` flanking area of the gene does not influence binding to Sp-1. Cancer Res 59:2825–2828
    Kang HJ, Kim SW, Kim HJ, Ahn SJ, Bae JY, Park SK, Kang D, Hirvonen A, Choe KJ, Noh DY (2002) Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Lett 178:175–180
    Mitrunen K, Hirvonen A (2003) Molecular epidemiology of sporadic breast cancer: the role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544:9–41
    Rajeswari N, Ahuja YR, Malini U, Chandrashekar S, Balakrishna N, Rao KV, Khar A (2000) Risk assessment in first degree female relatives of breast cancer patients using the alkaline comet assay. Carcinogenesis 21:557–561
    Li D, Wang M, Dhingra K, Hittelman WN (1996) Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 56:287–293
    Smith TR, Miller MS, Lohman KK, Case LD, Hu JJ (2003) DNA damage and breast cancer. Carcinogenesis 24:883–889
    Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarjan AT, Norppa H, Shuker DE, Tice R, Waters MD, Aitio A (2000) IPCS guidelines for the monitoring on genotoxic effects of carcinogens in humans. Mutat Res 463:111–173
    Norppa H (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149:309–343
    Hagmar L, Bonassi S, Strömberg U, Brøgger A, Knudsen L, Norppa H, Reuterwall C (1998) Chromosomal aberrations in lymphocytes predict human cancer—a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58:4117–4121
    Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, Heikkilä P, Wanders S, Wilhardt P, Hansteen IL, Knudsen L, Norppa H (2000) Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res 60:1619–1625
    Fucić A, Znaor A, Strnad M, van der Hel O, Aleksandrov A, Miskov S, Grah J, Sedlar M, Jazbec AM, Ceppi M, Vermeulen R, Boffetta P, Norppa H, Bonassi S (2007) Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia. Toxicol Lett 172:4–11
    Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81–95
    Collins AR (2004) The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26:249–261
    Singh NP, Mccoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low DNA levels of DNA damage in individual cells. Exp Cell Res 175:184–191
    Lou J, He J, Zheng W, Jin L, Chen Z, Chen S, Lin Y, Xu S (2007) Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay. Mutat Res 617:104–110
    Fenech M (2002) Biomarkers of genetic damage for cancer epidemiology. Toxicology 181:411–416
    Bolognesi C, Lando C, Forni A, Landini E, Scarpato R, Migliore L, Bonassi S (1999) Chromosomal damage and ageing: effect on micronuclei frequency in peripheral blood lymphocytes. Age Ageing 28:393–397
    Varga D, Hoegel J, Maier C, Jainta S, Hoehne M, Patino-Garcia B, Michell I, Schwarz-Boeger U, Kiechle M, Kreienberg R, Vogel W (2006) On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. Mutagenesis 21:313–320
    Pastor S, Creus A, Parrón T, Cebulska-Wasilewska A, Siffel C, Piperakis S, Marcos R (2003) Biomonitoring of four European populations occupationally exposed to pesticides: use of micronuclei as biomarkers. Mutagenesis 18:249–258
    Kopjar N, Zeljezic D, Garaj-Vrhovac V (2006) Evaluation of DNA damage in white blood cells of healthy human volunteers using alkaline comet assay and the chromosome aberration test. Acta Biochem Pol 53:321–336
    Schabath MB, Spitz MR, Grossman HB, Zhang K, Dinney CP, Zheng PJ, Wu X (2002) Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst 95:540–547
    Hamurcu Z, Dönmez-Altuntas H, Patiroglu T (2008) Basal level micronucleus frequency in stimulated lymphocytes of untreated patients with leukemia. Cancer Genet Cytogenet 180:140–144
    Hoffmann H, Speit G (2005) Assessment of DNA damage in peripheral blood of heavy smokers with the comet assay and micronucleus test. Mutat Res 581:105–114
    Bonassi S, Neri N, Lando C, Ceppi M, Lin YP, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Fenech M (2003) Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the human micronucleus project. Mutat Res 543:155–166
    Vijg J (2004) Impact of genome instability on transcription regulation of aging and senescence. Mech Ageing Dev 125:747–753
    Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S (1999) The human micronucleus project: an international collaborative study on the use of micronucleus technique for measuring DNA damage in humans. Mutat Res 428:271–283
    Lockett KL, Hall MC, Clark PE, Chuang SC, Robinson B, Lin HY, Su LJ, Hu JJ (2006) DNA damage levels in prostate cancer cases and controls. Carcinogenesis 27:1187–1193
    Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A, Fabianova E, Fucić A, Hagmar L, JoksiE G, Martelli A, Migliore L, Mirkova E, Scarfi MR, Zijno A, Norppa H, Fenech M (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625–631
    Synowiec E, Stefanska J, Morawiec Z, Blasiak J, Wozniak K (2008) Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res 648:65–72
    Thompson LH, Schild D (2002) Recombinational DNA repair and human disease. Mutat Res 509:49–78